Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ochronosis | 2 | 2021 | 7 | 1.640 |
Why?
|
Alkaptonuria | 2 | 2021 | 13 | 1.630 |
Why?
|
Histiocytosis | 2 | 2020 | 39 | 1.200 |
Why?
|
Skin Neoplasms | 24 | 2022 | 5686 | 1.070 |
Why?
|
Keratosis, Seborrheic | 1 | 2022 | 27 | 0.860 |
Why?
|
Cellulitis | 2 | 2020 | 206 | 0.780 |
Why?
|
Liver Diseases, Alcoholic | 12 | 1999 | 161 | 0.720 |
Why?
|
Histiocytes | 1 | 2020 | 103 | 0.710 |
Why?
|
Sarcoma, Kaposi | 5 | 2006 | 370 | 0.710 |
Why?
|
Nevus | 4 | 2012 | 204 | 0.690 |
Why?
|
Melanocytes | 4 | 2015 | 515 | 0.590 |
Why?
|
Carcinoma, Squamous Cell | 6 | 2022 | 4034 | 0.550 |
Why?
|
Lymphatic Vessels | 1 | 2020 | 353 | 0.540 |
Why?
|
Melanoma | 12 | 2015 | 5510 | 0.480 |
Why?
|
Skin | 10 | 2021 | 4364 | 0.420 |
Why?
|
Lip Neoplasms | 3 | 1998 | 37 | 0.410 |
Why?
|
Nevus, Pigmented | 2 | 2015 | 219 | 0.410 |
Why?
|
Lymphatic Diseases | 1 | 2013 | 324 | 0.410 |
Why?
|
Skin Aging | 2 | 2012 | 127 | 0.400 |
Why?
|
Lasers, Gas | 1 | 2012 | 93 | 0.390 |
Why?
|
Immunohistochemistry | 17 | 2020 | 11366 | 0.370 |
Why?
|
Lasers, Solid-State | 1 | 2012 | 169 | 0.360 |
Why?
|
Carcinoma, Basal Cell | 4 | 2011 | 545 | 0.360 |
Why?
|
Receptor, Nerve Growth Factor | 1 | 2009 | 48 | 0.350 |
Why?
|
Lupus Erythematosus, Cutaneous | 1 | 2010 | 58 | 0.340 |
Why?
|
Wound Healing | 1 | 2020 | 2785 | 0.330 |
Why?
|
Ki-67 Antigen | 2 | 2009 | 644 | 0.330 |
Why?
|
Terminology as Topic | 2 | 2012 | 1547 | 0.310 |
Why?
|
Shoulder Joint | 1 | 2013 | 695 | 0.290 |
Why?
|
Laser Therapy | 2 | 2012 | 1072 | 0.290 |
Why?
|
Acquired Immunodeficiency Syndrome | 3 | 2006 | 2232 | 0.290 |
Why?
|
Herpesvirus 8, Human | 2 | 2005 | 258 | 0.280 |
Why?
|
Face | 1 | 2012 | 994 | 0.280 |
Why?
|
Purpura | 2 | 2004 | 122 | 0.270 |
Why?
|
Osteoarthritis | 1 | 2013 | 1036 | 0.270 |
Why?
|
Epidermis | 3 | 2022 | 528 | 0.250 |
Why?
|
Acanthamoeba | 1 | 2003 | 13 | 0.240 |
Why?
|
Skin Diseases, Parasitic | 1 | 2003 | 13 | 0.240 |
Why?
|
Amebiasis | 1 | 2003 | 34 | 0.240 |
Why?
|
Necrobiosis Lipoidica | 1 | 2023 | 12 | 0.230 |
Why?
|
Scurvy | 1 | 2003 | 29 | 0.230 |
Why?
|
Palpation | 1 | 2003 | 167 | 0.230 |
Why?
|
Pigmentation | 1 | 2003 | 148 | 0.220 |
Why?
|
Fibroadenoma | 1 | 2002 | 43 | 0.210 |
Why?
|
Cystadenoma | 1 | 2002 | 84 | 0.210 |
Why?
|
Proto-Oncogene Proteins c-kit | 2 | 2005 | 776 | 0.200 |
Why?
|
Thromboxane B2 | 4 | 1997 | 152 | 0.200 |
Why?
|
Hydroquinones | 1 | 2021 | 36 | 0.200 |
Why?
|
Diagnosis, Differential | 12 | 2020 | 12959 | 0.200 |
Why?
|
Proliferating Cell Nuclear Antigen | 5 | 1996 | 285 | 0.190 |
Why?
|
Eyelid Neoplasms | 1 | 2002 | 94 | 0.190 |
Why?
|
Foot Diseases | 2 | 2019 | 143 | 0.190 |
Why?
|
Isothiocyanates | 1 | 2020 | 51 | 0.190 |
Why?
|
Drug Eruptions | 2 | 2014 | 297 | 0.180 |
Why?
|
Biopsy | 8 | 2020 | 6756 | 0.180 |
Why?
|
Disaccharides | 1 | 2020 | 171 | 0.180 |
Why?
|
S100 Proteins | 2 | 1998 | 259 | 0.180 |
Why?
|
Rats, Wistar | 14 | 1999 | 1901 | 0.170 |
Why?
|
Melanoma, Amelanotic | 1 | 2019 | 18 | 0.170 |
Why?
|
Keratoacanthoma | 1 | 1999 | 33 | 0.170 |
Why?
|
Prototheca | 1 | 1998 | 3 | 0.170 |
Why?
|
Erythema | 1 | 2020 | 257 | 0.170 |
Why?
|
Lupus Erythematosus, Systemic | 3 | 2010 | 2104 | 0.160 |
Why?
|
Carcinoma | 4 | 2020 | 2375 | 0.160 |
Why?
|
Neoplastic Stem Cells | 1 | 2006 | 1376 | 0.160 |
Why?
|
Cimetidine | 2 | 1996 | 78 | 0.160 |
Why?
|
Pathology | 1 | 2021 | 272 | 0.160 |
Why?
|
Skin Diseases, Infectious | 1 | 1998 | 74 | 0.160 |
Why?
|
Viral Proteins | 1 | 2005 | 1900 | 0.150 |
Why?
|
Neoplasm Invasiveness | 6 | 2014 | 3616 | 0.150 |
Why?
|
Multiple Endocrine Neoplasia Type 1 | 1 | 2017 | 46 | 0.150 |
Why?
|
Thromboxane A2 | 1 | 1997 | 92 | 0.150 |
Why?
|
Tissue Fixation | 2 | 2015 | 241 | 0.150 |
Why?
|
Interferon-alpha | 3 | 2019 | 895 | 0.140 |
Why?
|
Thyroid Gland | 1 | 2003 | 1173 | 0.140 |
Why?
|
Abdominal Wall | 1 | 2018 | 157 | 0.140 |
Why?
|
Humans | 69 | 2023 | 744343 | 0.140 |
Why?
|
Propionates | 1 | 1996 | 169 | 0.140 |
Why?
|
Benzoquinones | 1 | 1996 | 201 | 0.140 |
Why?
|
Nail Diseases | 1 | 2016 | 51 | 0.130 |
Why?
|
Fibroma | 1 | 2017 | 212 | 0.130 |
Why?
|
Toxemia | 1 | 1995 | 14 | 0.130 |
Why?
|
Exanthema | 1 | 2020 | 501 | 0.130 |
Why?
|
Nucleolus Organizer Region | 1 | 1995 | 26 | 0.130 |
Why?
|
Paget's Disease, Mammary | 1 | 1995 | 19 | 0.130 |
Why?
|
Transforming Growth Factor beta | 3 | 1997 | 2007 | 0.120 |
Why?
|
Liver | 12 | 2000 | 7474 | 0.120 |
Why?
|
Nuclear Proteins | 5 | 2005 | 5853 | 0.120 |
Why?
|
Carcinoma, Lobular | 1 | 1998 | 484 | 0.120 |
Why?
|
Leg Ulcer | 1 | 2014 | 69 | 0.120 |
Why?
|
Onycholysis | 1 | 2013 | 3 | 0.110 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2018 | 484 | 0.110 |
Why?
|
Epidermolysis Bullosa Acquisita | 1 | 2013 | 13 | 0.110 |
Why?
|
Hamartoma | 2 | 1993 | 238 | 0.110 |
Why?
|
Nipples | 1 | 1995 | 219 | 0.110 |
Why?
|
Mucormycosis | 1 | 2014 | 97 | 0.110 |
Why?
|
Hemangiosarcoma | 2 | 1995 | 239 | 0.110 |
Why?
|
Facial Neoplasms | 2 | 2004 | 121 | 0.110 |
Why?
|
Carcinoma in Situ | 1 | 1998 | 806 | 0.110 |
Why?
|
Livedo Reticularis | 1 | 2011 | 5 | 0.100 |
Why?
|
Ethanol | 3 | 1997 | 1342 | 0.100 |
Why?
|
Male | 47 | 2020 | 350118 | 0.100 |
Why?
|
Dermatology | 1 | 2021 | 872 | 0.100 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 1995 | 1155 | 0.100 |
Why?
|
Scalp | 2 | 1993 | 380 | 0.100 |
Why?
|
Middle Aged | 27 | 2020 | 213383 | 0.100 |
Why?
|
Opportunistic Infections | 1 | 2014 | 389 | 0.090 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 1995 | 547 | 0.090 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 1998 | 1101 | 0.090 |
Why?
|
Trichotillomania | 1 | 1992 | 172 | 0.090 |
Why?
|
Ectoparasitic Infestations | 1 | 2009 | 12 | 0.090 |
Why?
|
Rats | 17 | 1999 | 24260 | 0.090 |
Why?
|
Single-Blind Method | 2 | 2012 | 1590 | 0.090 |
Why?
|
Xanthogranuloma, Juvenile | 1 | 1989 | 17 | 0.090 |
Why?
|
Ixodes | 1 | 2009 | 39 | 0.090 |
Why?
|
Ecthyma, Contagious | 1 | 2009 | 3 | 0.090 |
Why?
|
Immunocompromised Host | 2 | 2014 | 847 | 0.090 |
Why?
|
Calcinosis | 1 | 1998 | 1499 | 0.090 |
Why?
|
Amyloidosis | 1 | 2016 | 795 | 0.080 |
Why?
|
Photography | 1 | 2012 | 520 | 0.080 |
Why?
|
HIV | 2 | 2008 | 1604 | 0.080 |
Why?
|
Bites and Stings | 1 | 2009 | 91 | 0.080 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2023 | 3336 | 0.080 |
Why?
|
Islam | 1 | 2009 | 69 | 0.080 |
Why?
|
Cholesterol | 1 | 1997 | 2917 | 0.080 |
Why?
|
Darier Disease | 1 | 1987 | 12 | 0.080 |
Why?
|
Sweet Syndrome | 1 | 2008 | 47 | 0.080 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 1997 | 4420 | 0.080 |
Why?
|
Neoplasm Metastasis | 1 | 1998 | 4851 | 0.080 |
Why?
|
AIDS-Related Opportunistic Infections | 2 | 2004 | 657 | 0.080 |
Why?
|
Dendritic Cells | 1 | 1998 | 2725 | 0.070 |
Why?
|
Oligopeptides | 1 | 2013 | 1189 | 0.070 |
Why?
|
Neoplasms, Second Primary | 1 | 1995 | 1061 | 0.070 |
Why?
|
Immunoenzyme Techniques | 2 | 2004 | 1799 | 0.070 |
Why?
|
Fetal Proteins | 1 | 2006 | 94 | 0.070 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2019 | 9239 | 0.070 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 2 | 1997 | 329 | 0.070 |
Why?
|
Liver Cirrhosis, Alcoholic | 2 | 1997 | 65 | 0.070 |
Why?
|
Intermediate Filament Proteins | 1 | 2006 | 269 | 0.070 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 1993 | 949 | 0.070 |
Why?
|
RNA, Messenger | 5 | 1997 | 13033 | 0.070 |
Why?
|
Intestines | 1 | 1995 | 1924 | 0.070 |
Why?
|
Female | 26 | 2020 | 380194 | 0.070 |
Why?
|
Syphilis | 1 | 2008 | 227 | 0.070 |
Why?
|
Cell Adhesion Molecules, Neuronal | 1 | 2006 | 265 | 0.060 |
Why?
|
Antigens, Neoplasm | 1 | 1993 | 1988 | 0.060 |
Why?
|
Endothelium | 3 | 1996 | 778 | 0.060 |
Why?
|
Sulbactam | 1 | 2004 | 26 | 0.060 |
Why?
|
Tissue Array Analysis | 1 | 2006 | 553 | 0.060 |
Why?
|
Breast Neoplasms | 4 | 1998 | 20822 | 0.060 |
Why?
|
Proto-Oncogene Proteins | 1 | 2017 | 4554 | 0.060 |
Why?
|
Antigens, CD | 3 | 2008 | 4026 | 0.060 |
Why?
|
Neovascularization, Pathologic | 1 | 1995 | 2635 | 0.060 |
Why?
|
Ampicillin | 1 | 2004 | 139 | 0.060 |
Why?
|
Analysis of Variance | 2 | 2012 | 6365 | 0.060 |
Why?
|
Matrix Metalloproteinases | 1 | 2006 | 391 | 0.060 |
Why?
|
Cell Differentiation | 2 | 2020 | 11483 | 0.060 |
Why?
|
Pentamidine | 1 | 2003 | 45 | 0.060 |
Why?
|
Adult | 20 | 2018 | 214055 | 0.060 |
Why?
|
Itraconazole | 1 | 2003 | 43 | 0.060 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2014 | 2043 | 0.060 |
Why?
|
Tetracyclines | 1 | 2004 | 60 | 0.060 |
Why?
|
Biopsy, Needle | 3 | 2014 | 1641 | 0.060 |
Why?
|
Antiparasitic Agents | 1 | 2003 | 41 | 0.060 |
Why?
|
Skin Diseases, Vesiculobullous | 1 | 2004 | 85 | 0.060 |
Why?
|
Necrosis | 3 | 2014 | 1643 | 0.060 |
Why?
|
Receptor, trkC | 1 | 2003 | 68 | 0.060 |
Why?
|
Antiprotozoal Agents | 1 | 2003 | 86 | 0.060 |
Why?
|
Pigmentation Disorders | 1 | 2004 | 101 | 0.060 |
Why?
|
Skin Diseases | 2 | 2021 | 1065 | 0.060 |
Why?
|
Protein Precursors | 1 | 1987 | 1154 | 0.060 |
Why?
|
Cysts | 2 | 2002 | 678 | 0.050 |
Why?
|
Hidrocystoma | 1 | 2002 | 11 | 0.050 |
Why?
|
HIV Infections | 2 | 2008 | 16718 | 0.050 |
Why?
|
Lipid Peroxidation | 4 | 1997 | 270 | 0.050 |
Why?
|
Hepatitis C | 1 | 2013 | 1591 | 0.050 |
Why?
|
Isoenzymes | 2 | 1997 | 1726 | 0.050 |
Why?
|
Minocycline | 1 | 2003 | 163 | 0.050 |
Why?
|
Neoplasm Proteins | 1 | 1995 | 3703 | 0.050 |
Why?
|
Color | 1 | 2003 | 307 | 0.050 |
Why?
|
Dermatitis | 1 | 2004 | 197 | 0.050 |
Why?
|
Fish Oils | 2 | 1996 | 470 | 0.050 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2006 | 2942 | 0.050 |
Why?
|
Thoracic Wall | 1 | 2003 | 203 | 0.050 |
Why?
|
Radiation Chimera | 1 | 2001 | 223 | 0.050 |
Why?
|
Phosphoglucomutase | 1 | 2001 | 6 | 0.050 |
Why?
|
Remission Induction | 2 | 2004 | 2386 | 0.050 |
Why?
|
Crohn Disease | 2 | 2013 | 2303 | 0.050 |
Why?
|
In Situ Hybridization | 1 | 2005 | 1950 | 0.050 |
Why?
|
Chronic Disease | 3 | 2010 | 9146 | 0.050 |
Why?
|
Ovarian Neoplasms | 1 | 2018 | 4838 | 0.050 |
Why?
|
Sweat Gland Neoplasms | 1 | 2002 | 108 | 0.050 |
Why?
|
Injections, Subcutaneous | 1 | 2002 | 666 | 0.050 |
Why?
|
Giant Cells | 1 | 2001 | 187 | 0.050 |
Why?
|
Aged | 10 | 2020 | 163280 | 0.050 |
Why?
|
Antiviral Agents | 1 | 2013 | 2987 | 0.050 |
Why?
|
Dietary Fats | 3 | 1997 | 2017 | 0.050 |
Why?
|
Treatment Outcome | 6 | 2014 | 63114 | 0.040 |
Why?
|
Bone Marrow Transplantation | 2 | 2014 | 2765 | 0.040 |
Why?
|
Pyoderma Gangrenosum | 1 | 2001 | 76 | 0.040 |
Why?
|
Aged, 80 and over | 7 | 2014 | 57776 | 0.040 |
Why?
|
Corn Oil | 2 | 1996 | 29 | 0.040 |
Why?
|
Patient Satisfaction | 1 | 2012 | 3396 | 0.040 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2004 | 624 | 0.040 |
Why?
|
Granuloma | 1 | 2002 | 319 | 0.040 |
Why?
|
Prognosis | 6 | 2006 | 29063 | 0.040 |
Why?
|
Lymphocyte Depletion | 1 | 2001 | 608 | 0.040 |
Why?
|
Acute Disease | 1 | 2010 | 7149 | 0.040 |
Why?
|
Animals | 21 | 2009 | 168757 | 0.040 |
Why?
|
Isoantigens | 1 | 2001 | 567 | 0.040 |
Why?
|
Immunophenotyping | 1 | 2004 | 1880 | 0.040 |
Why?
|
Severity of Illness Index | 2 | 2013 | 15540 | 0.040 |
Why?
|
Phosphoproteins | 2 | 2005 | 2440 | 0.040 |
Why?
|
DNA, Viral | 1 | 2005 | 2225 | 0.040 |
Why?
|
Glycoproteins | 1 | 2006 | 2263 | 0.040 |
Why?
|
Sampling Studies | 2 | 2014 | 623 | 0.040 |
Why?
|
Carcinoma, Verrucous | 1 | 1998 | 23 | 0.040 |
Why?
|
Microscopy, Confocal | 1 | 2004 | 1970 | 0.040 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2002 | 604 | 0.040 |
Why?
|
Thromboxane-A Synthase | 1 | 1997 | 34 | 0.040 |
Why?
|
Multiple Myeloma | 1 | 2016 | 5181 | 0.040 |
Why?
|
Receptors, Thromboxane | 1 | 1997 | 31 | 0.040 |
Why?
|
Sensitivity and Specificity | 3 | 2015 | 14722 | 0.040 |
Why?
|
Dinoprost | 2 | 1996 | 138 | 0.040 |
Why?
|
Antibodies, Monoclonal | 1 | 1995 | 9274 | 0.040 |
Why?
|
Skin Diseases, Viral | 1 | 1997 | 21 | 0.040 |
Why?
|
Lymph Nodes | 2 | 2008 | 3474 | 0.040 |
Why?
|
Inflammation | 1 | 1997 | 10638 | 0.040 |
Why?
|
Up-Regulation | 1 | 2006 | 4217 | 0.040 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 1998 | 294 | 0.040 |
Why?
|
Adenocarcinoma | 1 | 1995 | 6364 | 0.040 |
Why?
|
Pain | 1 | 2012 | 4986 | 0.040 |
Why?
|
Fatty Liver, Alcoholic | 1 | 1997 | 40 | 0.040 |
Why?
|
Transforming Growth Factor alpha | 1 | 1997 | 135 | 0.040 |
Why?
|
Sentinel Lymph Node Biopsy | 2 | 2014 | 709 | 0.040 |
Why?
|
Soft Tissue Infections | 1 | 1998 | 155 | 0.040 |
Why?
|
Cell Division | 4 | 1996 | 4568 | 0.040 |
Why?
|
Paclitaxel | 1 | 2004 | 1708 | 0.030 |
Why?
|
Protein Deficiency | 1 | 1996 | 61 | 0.030 |
Why?
|
Stereotaxic Techniques | 1 | 1998 | 536 | 0.030 |
Why?
|
S Phase | 2 | 1994 | 423 | 0.030 |
Why?
|
Transplantation, Homologous | 2 | 2001 | 4776 | 0.030 |
Why?
|
Antigens, CD1 | 1 | 1998 | 437 | 0.030 |
Why?
|
Arm | 1 | 1999 | 589 | 0.030 |
Why?
|
Polymerase Chain Reaction | 1 | 2005 | 6171 | 0.030 |
Why?
|
Oxazoles | 1 | 1997 | 189 | 0.030 |
Why?
|
Hepatitis B, Chronic | 1 | 2000 | 393 | 0.030 |
Why?
|
Hutchinson's Melanotic Freckle | 1 | 1995 | 19 | 0.030 |
Why?
|
Mastectomy, Simple | 1 | 1995 | 24 | 0.030 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2004 | 2455 | 0.030 |
Why?
|
Cytochrome P-450 Enzyme System | 2 | 1994 | 419 | 0.030 |
Why?
|
Histocytological Preparation Techniques | 1 | 1995 | 30 | 0.030 |
Why?
|
Antineoplastic Agents | 2 | 2011 | 13695 | 0.030 |
Why?
|
Dysplastic Nevus Syndrome | 1 | 1995 | 63 | 0.030 |
Why?
|
Animal Feed | 1 | 1995 | 110 | 0.030 |
Why?
|
Herpes Zoster | 1 | 1997 | 264 | 0.030 |
Why?
|
Peptides | 1 | 2006 | 4409 | 0.030 |
Why?
|
Cell Count | 1 | 1998 | 1856 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 4751 | 0.030 |
Why?
|
Clobetasol | 1 | 2014 | 34 | 0.030 |
Why?
|
Piperazines | 1 | 2004 | 2488 | 0.030 |
Why?
|
Oxidoreductases, N-Demethylating | 1 | 1994 | 115 | 0.030 |
Why?
|
Paraffin Embedding | 1 | 2015 | 299 | 0.030 |
Why?
|
Neoplasms, Connective Tissue | 1 | 1994 | 40 | 0.030 |
Why?
|
Axilla | 2 | 1993 | 595 | 0.030 |
Why?
|
Cell Proliferation | 1 | 2009 | 10481 | 0.030 |
Why?
|
Arachidonic Acids | 1 | 1994 | 299 | 0.030 |
Why?
|
Nerve Tissue Proteins | 1 | 2006 | 4462 | 0.030 |
Why?
|
Drug Therapy, Combination | 1 | 2003 | 6489 | 0.030 |
Why?
|
Neoplasm Staging | 4 | 2014 | 11031 | 0.030 |
Why?
|
Formaldehyde | 1 | 1995 | 353 | 0.030 |
Why?
|
T-Lymphocyte Subsets | 1 | 2001 | 1838 | 0.030 |
Why?
|
G1 Phase | 1 | 1994 | 415 | 0.030 |
Why?
|
Sebaceous Gland Neoplasms | 1 | 1993 | 39 | 0.030 |
Why?
|
Pyrimidines | 1 | 2004 | 2942 | 0.030 |
Why?
|
Immune Tolerance | 1 | 2001 | 2258 | 0.030 |
Why?
|
Hyaluronic Acid | 1 | 1996 | 491 | 0.030 |
Why?
|
Killer Cells, Natural | 1 | 2001 | 2133 | 0.030 |
Why?
|
Oximes | 1 | 2014 | 311 | 0.030 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 1997 | 1213 | 0.030 |
Why?
|
Anti-Bacterial Agents | 3 | 2008 | 7181 | 0.030 |
Why?
|
Hematopoiesis | 1 | 2001 | 2072 | 0.030 |
Why?
|
Administration, Cutaneous | 1 | 2014 | 711 | 0.030 |
Why?
|
Pyrimidinones | 1 | 2014 | 371 | 0.030 |
Why?
|
Hepatitis C, Chronic | 1 | 2000 | 1031 | 0.020 |
Why?
|
Follow-Up Studies | 5 | 2014 | 39050 | 0.020 |
Why?
|
Dermoscopy | 1 | 2011 | 56 | 0.020 |
Why?
|
Dietary Proteins | 1 | 1996 | 963 | 0.020 |
Why?
|
NF-kappa B | 1 | 1999 | 2499 | 0.020 |
Why?
|
Cell Cycle | 2 | 1996 | 2967 | 0.020 |
Why?
|
Cytokines | 2 | 2008 | 7322 | 0.020 |
Why?
|
Tick-Borne Diseases | 1 | 2009 | 34 | 0.020 |
Why?
|
Intestine, Small | 1 | 1996 | 1241 | 0.020 |
Why?
|
Fatty Acids | 1 | 1997 | 1809 | 0.020 |
Why?
|
Immunologic Factors | 1 | 2019 | 1580 | 0.020 |
Why?
|
Stevens-Johnson Syndrome | 1 | 2013 | 280 | 0.020 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 1993 | 332 | 0.020 |
Why?
|
Ileal Neoplasms | 1 | 1989 | 21 | 0.020 |
Why?
|
Pyridones | 1 | 2014 | 712 | 0.020 |
Why?
|
Hair Follicle | 1 | 2011 | 209 | 0.020 |
Why?
|
Remission, Spontaneous | 1 | 2009 | 382 | 0.020 |
Why?
|
Middle East | 1 | 2009 | 219 | 0.020 |
Why?
|
Liver Transplantation | 1 | 2000 | 2119 | 0.020 |
Why?
|
Administration, Oral | 2 | 2008 | 3913 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2004 | 5535 | 0.020 |
Why?
|
Treponema pallidum | 1 | 2008 | 40 | 0.020 |
Why?
|
Immunoelectrophoresis | 1 | 1987 | 110 | 0.020 |
Why?
|
Pregnancy | 1 | 2009 | 29144 | 0.020 |
Why?
|
Colon | 1 | 1996 | 1772 | 0.020 |
Why?
|
Imidazoles | 1 | 2014 | 1206 | 0.020 |
Why?
|
Survival Analysis | 3 | 2000 | 10252 | 0.020 |
Why?
|
Thumb | 1 | 2009 | 227 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 2 | 1996 | 8301 | 0.020 |
Why?
|
Liver Cirrhosis | 1 | 1997 | 1863 | 0.020 |
Why?
|
Erythema Nodosum | 1 | 1986 | 30 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2017 | 2849 | 0.020 |
Why?
|
Angiomatosis | 1 | 1986 | 49 | 0.020 |
Why?
|
Chromatography, Gel | 1 | 1987 | 668 | 0.020 |
Why?
|
Photosensitivity Disorders | 1 | 1986 | 78 | 0.020 |
Why?
|
Injections, Intramuscular | 1 | 2008 | 552 | 0.020 |
Why?
|
Lupus Erythematosus, Discoid | 1 | 1986 | 49 | 0.020 |
Why?
|
Leprosy | 1 | 1986 | 124 | 0.020 |
Why?
|
Nitric Oxide | 1 | 1995 | 2132 | 0.020 |
Why?
|
Doxycycline | 1 | 2008 | 326 | 0.020 |
Why?
|
Bipolar Disorder | 1 | 2003 | 5027 | 0.020 |
Why?
|
Polyarteritis Nodosa | 1 | 1986 | 66 | 0.020 |
Why?
|
Sheep | 1 | 2009 | 1437 | 0.020 |
Why?
|
Chromatography, Affinity | 1 | 1987 | 549 | 0.020 |
Why?
|
Transglutaminases | 1 | 1987 | 194 | 0.020 |
Why?
|
Recurrence | 2 | 2000 | 8340 | 0.020 |
Why?
|
Lipids | 1 | 1997 | 3305 | 0.020 |
Why?
|
Lower Extremity | 1 | 2014 | 1158 | 0.020 |
Why?
|
Endotoxins | 2 | 1999 | 527 | 0.020 |
Why?
|
Lymphatic Metastasis | 1 | 1993 | 2924 | 0.020 |
Why?
|
Penicillins | 1 | 2008 | 380 | 0.020 |
Why?
|
Molecular Weight | 1 | 1987 | 2255 | 0.020 |
Why?
|
Age Factors | 2 | 1994 | 18370 | 0.020 |
Why?
|
Cyclooxygenase 2 | 2 | 1997 | 611 | 0.020 |
Why?
|
Spirituality | 1 | 2009 | 405 | 0.020 |
Why?
|
Parenteral Nutrition, Total | 1 | 1985 | 302 | 0.020 |
Why?
|
Receptors, Platelet-Derived Growth Factor | 1 | 2004 | 180 | 0.020 |
Why?
|
Aminoquinolines | 1 | 2004 | 109 | 0.020 |
Why?
|
Fallopian Tube Diseases | 1 | 2004 | 62 | 0.020 |
Why?
|
Forehead | 1 | 2004 | 69 | 0.020 |
Why?
|
Stomach Neoplasms | 1 | 1994 | 1333 | 0.020 |
Why?
|
Uterine Neoplasms | 1 | 1993 | 1513 | 0.010 |
Why?
|
Disease Progression | 2 | 2014 | 13284 | 0.010 |
Why?
|
Sickle Cell Trait | 1 | 2004 | 81 | 0.010 |
Why?
|
Hemangioma | 1 | 1989 | 738 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 1996 | 4456 | 0.010 |
Why?
|
Base Sequence | 1 | 1995 | 12797 | 0.010 |
Why?
|
Ovarian Diseases | 1 | 2004 | 139 | 0.010 |
Why?
|
Fluorescent Antibody Technique | 1 | 1987 | 2505 | 0.010 |
Why?
|
Abdominal Abscess | 1 | 2004 | 154 | 0.010 |
Why?
|
Anemia, Hemolytic, Autoimmune | 1 | 2004 | 142 | 0.010 |
Why?
|
Alopecia | 1 | 1986 | 382 | 0.010 |
Why?
|
Suppuration | 1 | 2002 | 56 | 0.010 |
Why?
|
Molecular Targeted Therapy | 1 | 2014 | 2727 | 0.010 |
Why?
|
Mohs Surgery | 1 | 2004 | 197 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 1995 | 18111 | 0.010 |
Why?
|
Cattle | 1 | 1987 | 3922 | 0.010 |
Why?
|
Cohort Studies | 2 | 2015 | 40561 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2011 | 6622 | 0.010 |
Why?
|
Arthritis | 1 | 1986 | 659 | 0.010 |
Why?
|
Pruritus | 1 | 2004 | 361 | 0.010 |
Why?
|
H-2 Antigens | 1 | 2001 | 366 | 0.010 |
Why?
|
Diet | 2 | 1996 | 7939 | 0.010 |
Why?
|
Proteins | 1 | 1996 | 6103 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2009 | 6386 | 0.010 |
Why?
|
Leukocyte Count | 1 | 2004 | 1588 | 0.010 |
Why?
|
Sunlight | 1 | 2002 | 325 | 0.010 |
Why?
|
Macrophages | 1 | 1995 | 5655 | 0.010 |
Why?
|
Lipid Peroxides | 1 | 1999 | 73 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2021 | 77449 | 0.010 |
Why?
|
Sex Factors | 1 | 1994 | 10397 | 0.010 |
Why?
|
Survival Rate | 1 | 2014 | 12788 | 0.010 |
Why?
|
Benzamides | 1 | 2004 | 1379 | 0.010 |
Why?
|
I-kappa B Proteins | 1 | 1999 | 225 | 0.010 |
Why?
|
Adoptive Transfer | 1 | 2001 | 844 | 0.010 |
Why?
|
Disease Models, Animal | 3 | 2009 | 18029 | 0.010 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2008 | 2540 | 0.010 |
Why?
|
Risk Assessment | 2 | 2014 | 23338 | 0.010 |
Why?
|
Thiobarbituric Acid Reactive Substances | 1 | 1997 | 46 | 0.010 |
Why?
|
Transgenes | 1 | 2001 | 1009 | 0.010 |
Why?
|
Hepatitis, Alcoholic | 1 | 1999 | 103 | 0.010 |
Why?
|
Carbon Dioxide | 1 | 2002 | 1150 | 0.010 |
Why?
|
Diarrhea | 1 | 2004 | 1348 | 0.010 |
Why?
|
Incidence | 2 | 2013 | 20947 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 1995 | 10180 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 1993 | 15076 | 0.010 |
Why?
|
Alanine Transaminase | 1 | 1999 | 592 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2008 | 5524 | 0.010 |
Why?
|
Kupffer Cells | 1 | 1997 | 142 | 0.010 |
Why?
|
Chickenpox | 1 | 1997 | 131 | 0.010 |
Why?
|
Thrombocytopenia | 1 | 2004 | 1179 | 0.010 |
Why?
|
Absorption | 1 | 1996 | 248 | 0.010 |
Why?
|
Skin Transplantation | 1 | 2001 | 1074 | 0.010 |
Why?
|
NADPH Dehydrogenase | 1 | 1995 | 45 | 0.010 |
Why?
|
Endotoxemia | 1 | 1997 | 207 | 0.010 |
Why?
|
Mice | 3 | 2009 | 81183 | 0.010 |
Why?
|
Vimentin | 1 | 1996 | 261 | 0.010 |
Why?
|
NG-Nitroarginine Methyl Ester | 1 | 1995 | 255 | 0.010 |
Why?
|
Chemokines | 1 | 1999 | 970 | 0.010 |
Why?
|
Cytochrome P-450 CYP2E1 | 1 | 1994 | 36 | 0.010 |
Why?
|
Renal Dialysis | 1 | 2004 | 1786 | 0.010 |
Why?
|
Nitrogen | 1 | 1996 | 344 | 0.010 |
Why?
|
Time Factors | 2 | 1995 | 40075 | 0.010 |
Why?
|
F2-Isoprostanes | 1 | 1994 | 35 | 0.010 |
Why?
|
Microsomes, Liver | 1 | 1994 | 173 | 0.010 |
Why?
|
Fatty Acids, Unsaturated | 1 | 1997 | 546 | 0.010 |
Why?
|
Leucine | 1 | 1996 | 561 | 0.010 |
Why?
|
Enzyme Induction | 1 | 1994 | 475 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2004 | 3508 | 0.010 |
Why?
|
Serum Albumin | 1 | 1996 | 676 | 0.010 |
Why?
|
Ploidies | 1 | 1992 | 281 | 0.010 |
Why?
|
Immunoassay | 1 | 1996 | 752 | 0.010 |
Why?
|
Child | 2 | 2011 | 77709 | 0.010 |
Why?
|
von Willebrand Factor | 1 | 1996 | 669 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2008 | 8428 | 0.010 |
Why?
|
Arginine | 1 | 1995 | 944 | 0.010 |
Why?
|
Intestinal Mucosa | 2 | 1996 | 3036 | 0.010 |
Why?
|
Kidney Failure, Chronic | 1 | 2004 | 2538 | 0.010 |
Why?
|
Pilot Projects | 1 | 2004 | 8324 | 0.010 |
Why?
|
Graft Survival | 1 | 2001 | 3737 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2008 | 7880 | 0.010 |
Why?
|
Inflammation Mediators | 1 | 1999 | 1889 | 0.010 |
Why?
|
Down-Regulation | 1 | 1997 | 3002 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 1993 | 2645 | 0.010 |
Why?
|
Laboratories, Hospital | 1 | 1991 | 194 | 0.010 |
Why?
|
Surgical Flaps | 1 | 1998 | 1640 | 0.010 |
Why?
|
Infant, Newborn | 1 | 1989 | 25625 | 0.010 |
Why?
|
Collagen | 1 | 1997 | 2689 | 0.010 |
Why?
|
Risk Factors | 1 | 1995 | 72290 | 0.000 |
Why?
|
Insulin-Like Growth Factor I | 1 | 1996 | 2015 | 0.000 |
Why?
|
Infant | 1 | 1989 | 35136 | 0.000 |
Why?
|
DNA, Neoplasm | 1 | 1992 | 1758 | 0.000 |
Why?
|
Child, Preschool | 1 | 1989 | 41006 | 0.000 |
Why?
|
Mice, Knockout | 1 | 2001 | 14557 | 0.000 |
Why?
|
Ileum | 1 | 1989 | 565 | 0.000 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2001 | 2425 | 0.000 |
Why?
|
Weight Gain | 1 | 1996 | 2292 | 0.000 |
Why?
|
Drug Stability | 1 | 1985 | 291 | 0.000 |
Why?
|
United States | 2 | 2009 | 69872 | 0.000 |
Why?
|
Mice, Inbred C57BL | 1 | 2001 | 21827 | 0.000 |
Why?
|
Kidney Transplantation | 1 | 1998 | 4251 | 0.000 |
Why?
|
DNA-Binding Proteins | 1 | 1999 | 9648 | 0.000 |
Why?
|
Flow Cytometry | 1 | 1992 | 5974 | 0.000 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 1985 | 1572 | 0.000 |
Why?
|
Signal Transduction | 1 | 2004 | 23403 | 0.000 |
Why?
|
Adolescent | 1 | 1989 | 85781 | 0.000 |
Why?
|
Uterine Cervical Neoplasms | 1 | 1993 | 2020 | 0.000 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1985 | 2557 | 0.000 |
Why?
|
Massachusetts | 1 | 1991 | 8663 | 0.000 |
Why?
|
Postoperative Complications | 1 | 2000 | 15295 | 0.000 |
Why?
|
Registries | 1 | 1991 | 8089 | 0.000 |
Why?
|